Q3 2025 Holdings
Filed 2025-11-14 | 220 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $114.7M | 1,350,826 | 10.8% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $85.3M | 5,389,264 | 8.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $65.7M | 989,182 | 6.2% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $50.6M | 3,347,501 | 4.8% |
| EA Series Trust(BOXX) | ALPHA ARCH 1-3 | 02072L565 | $38.4M | 337,125 | 3.6% |
| Spdr S&P 500 ETF TR(SPY) | TR UNIT | 78462F103 | $36.4M | 54,684 | 3.4% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $36.1M | 2,241,753 | 3.4% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $31.1M | 2,113,153 | 2.9% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $30.3M | 45,500 | 2.8% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $29.4M | 868,780 | 2.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $28.5M | 518,921 | 2.7% |
| Septerna Inc(SEPN) | COM | 81734D104 | $22.1M | 1,176,491 | 2.1% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $14.3M | 1,469,098 | 1.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $14.2M | 273,414 | 1.3% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $13.2M | 2,903,226 | 1.2% |
| Rapt Therapeutics Inc(RAPT) | COM NEW | 75382E208 | $13.1M | 507,771 | 1.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $12.9M | 4,045,414 | 1.2% |
| Spdr Series Trust(BIL) | BLOOMBERG 1-3 MO | 78468R663 | $12.4M | 135,585 | 1.2% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $11.8M | 866,202 | 1.1% |
| Uniqure NV(QURE)Call | SHS | N90064101 | $11.7M | 200,000 | 1.1% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $11.1M | 1,880,073 | 1.0% |
| Monopar Therapeutics Inc(MNPR) | COM NEW | 61023L207 | $10.6M | 129,999 | 1.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $10.3M | 248,368 | 1.0% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $10.2M | 1,531,953 | 1.0% |
| CG Oncology Inc(CGON) | COM | 156944100 | $10.0M | 248,917 | 0.9% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $9.3M | 2,835,680 | 0.9% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $8.8M | 15,700 | 0.8% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $8.8M | 133,818 | 0.8% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $8.6M | 351,032 | 0.8% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $8.5M | 5,247,603 | 0.8% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $8.1M | 7,370,987 | 0.8% |
| Metsera Inc | COM | 59267L107 | $8.0M | 152,521 | 0.7% |
| Equillium Inc(EQ) | COM | 29446K106 | $8.0M | 5,559,988 | 0.7% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $7.9M | 750,000 | 0.7% |
| Uniqure NV(QURE) | SHS | N90064101 | $7.8M | 133,316 | 0.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $7.7M | 213,064 | 0.7% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $7.7M | 815,975 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.6M | 189,098 | 0.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $7.2M | 36,345 | 0.7% |
| Savara Inc(SVRA) | COM | 805111101 | $7.1M | 1,988,288 | 0.7% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $6.7M | 349,807 | 0.6% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $6.5M | 139,136 | 0.6% |
| AA Mission Acquisition Corp | ORD SHS CL A | G1000R101 | $6.1M | 578,359 | 0.6% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $5.8M | 501,228 | 0.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $5.5M | 51,450 | 0.5% |
| Oaktree Acquisition Corp III | UNIT 10/04/2029 | G6717R120 | $5.5M | 516,482 | 0.5% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $5.4M | 267,816 | 0.5% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $5.0M | 49,571 | 0.5% |
| Atai Life Sciences NV | SHS | N0731H103 | $4.8M | 913,242 | 0.5% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $4.7M | 11,200 | 0.4% |